Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://news.bmn.com/magazine/researchupdate?uid=UPDATE.Hollox0805200392

 
Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics
Mead S. et al.
Science 2003 300(5619):640-643
Full Text   
Molecular Evolution of the Mammalian Prion Protein
van Rheede T. et al.
Molecular Biology and Evolution 2003 20(1):111-121
8 May 2003
Commentary by Edward Hollox ed.hollox@nottingham.ac.uk  
Prion diseases, such as scrapie and bovine spongiform encepthalopathy (BSE) in animals and Creutzfeld-Jacob disease in humans, are transmissible neurodegenerative conditions. The infective agent is an aberrant form of PrP, a normal cellular protein, and causes recruitment of the normal cellular protein into aggregates, similar to the amyloid plaques seen in the brains of Alzheimer's disease patients.
 
Transmission of prion diseases within and between species is thought to involve the consumption of contaminated meat. For example, in the Fore tribe of Papua New Guinea, an increase in ritual cannibalism over the last century increased the incidence of a human prion disease called Kuru. When a government ban on cannibalism was put in place 50 years ago, the frequency of Kuru declined, although there are still rare cases, because of the long incubation times that are possible with prion diseases.

Previous work showed that individuals heterozygous for a polymorphism that changed a methionine to a valine in PrP were more frequent than expected in Fore women, suggesting that the homozygotes at this polymorphism may be rare because they were more likely to develop Kuru and die. This prompted Mead et al. to examine the frequency of this polymorphism in the PrP gene (PNRP) in different populations. They found methionine and valine alleles in every population they studied, with the highest frequency of the valine allele (55%) in the Fore. Analysis of variation at other polymorphic sites near the gene suggested that this polymorphism was around half a million years old, and had been maintained in all populations since that time. The PNRP gene also has an excess of high-frequency polymorphisms and a deficit of low-frequency polymorphisms when compared with an expected distribution model with no selection and a constant, or expanding, population size. Together, these data showed the action of balancing selection, or 'heterozygote advantage', on the PRNP gene.

The best-known example of balancing selection in humans is where heterozygotes for sickle cell anaemia (commonly at a glutamine/lysine polymorphism in beta globin) show mild symptoms of sickle cell anaemia but increased resistance to malaria. Could there be a similar advantage at the PNRP gene, with heterozygotes more resistant to prion diseases? If so, the data suggest that these prion diseases must have been a significant cause of death during human evolutionary history.

What prion diseases, and how were they transmitted? The authors speculate that cannibalism was widespread in the past, providing ideal conditions for the transmission of prion disease. There is some archaeological evidence for this, such as scratches and burn marks on Neanderthal bones, and human muscle protein in preserved human faeces (see Diamond, J. (2000) Nature 407). However, it is also likely that cross-species transmission occurred in prehistory. Brains of scavenged carcasses are nutritious, and only humans could use tools to open the skull to get at the meat. Furthermore, eating such tissue was the most likely transmission method in the most recent example of cross-species transmission: when BSE in cattle became vCJD in humans.

 

© Elsevier Limited 2003

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.